-+ 0.00%
-+ 0.00%
-+ 0.00%

AC Immune Reports Further Interim Results From Phase 2 Trial Of ACI-7104.056 Active Immunotherapy In Early Parkinson's Disease; Says Repeated Immunizations Amplify The Anti-a-syn Antibody Response

Benzinga·04/02/2025 10:04:28
Listen to the news

Interim results show positive antibody responses were effectively induced against the target antigen at week 6 after 2 immunizations and were further boosted by each additional immunization. 

Treatment with ACI-7104.056 induced an increase in anti-a-syn antibodies on average over 20-fold higher than the placebo background level after four immunizations.

ACI-7104.056 is well tolerated with no safety issues reported to date.